In our study, although BGC823/5-Fu-CSCs presented the higher expression levels of MDR1 and MRP1, it was more sensitive to the intervention of YQHY combined with 5-Fu, indicating that CSCs was the dominant cell group of YQHY in the treatment of reversing gastric cancer drug resistance. The gene discussed is ABCC1; the disease is gastric cancer.